Skip to main content
Clinical Trials/NCT06127121
NCT06127121
Recruiting
Not Applicable

A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients

M.D. Anderson Cancer Center1 site in 1 country60 target enrollmentStarted: November 2, 2023Last updated:
ConditionsCancer

Overview

Phase
Not Applicable
Status
Recruiting
Enrollment
60
Locations
1
Primary Endpoint
The Edmonton Symptom Assessment System, (ESAS) questionnaires

Overview

Brief Summary

To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.

Detailed Description

Primary objective:

  • To evaluate how engaging in a digital art activity might potentially cause changes in symptom reporting, based on pre/post self-reporting on the Edmonton Symptom Assessment System (ESAS) at time T3.

Secondary objectives:

  • To evaluate the changes in symptom reporting, based on pre/post self-reporting on ESAS at different times of the study (T1, T2).
  • To evaluate how a specific creative art making activity (T3), compared to an active control condition (T2; music listening) may or may not impact reporting ESAS.
  • To monitor potential changes in distress disclosure, based on the self-report scoring on the Distress Disclosure Index score at T0, T2 and T3.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age equal or greater than 18 years
  • Patients who are admitted in the hospital and have received a cancer diagnosis.
  • Suffering from solid cancer or hematological malignancy and receiving active treatment for their cancer.
  • Voluntary written consent.
  • Fluent in English or Spanish.

Exclusion Criteria

  • Not being able to use a digital tablet
  • Being speech impaired or vision impaired
  • Patients who are cognitively impaired and unable to read or consent for the study
  • Pregnant women

Outcomes

Primary Outcomes

The Edmonton Symptom Assessment System, (ESAS) questionnaires

Time Frame: through study completion; an average 1 year.

Score Scale (0-10) 0 No symptom-10 Worst possible

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials